Harano K, Nakao T, Nishio S, Katsuda T, et al. Neoadjuvant olaparib and pembrolizumab combination therapy in the treatment of patients with HRD-positive advanced ovarian cancer: A pilot study. Clin Cancer Res 2026 Jul 30. doi: 10.1158/1078-0432.CCR-25-4887.
PMID: 42531373